English
Home > Products > 2-Amino-3,5-dibromobenzaldehyde

China 2-Amino-3,5-dibromobenzaldehyde Factory

The buyer pleasure is our primary concentrate on. We uphold a consistent level of professionalism, excellent, credibility and service for 2-Amino-3,5-dibromobenzaldehyde,CAS NO 50910-55-9,50910-55-9,Bromhexine intermediate,Bromhexine advance intermediate, We are ready to cooperate with organization pals from at your home and abroad and make a great long term together.
2-Amino-3,5-dibromobenzaldehyde, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Related Products

Hot Products

  • 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride

    3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride

    Product Name:3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
    Molecular Formula:C6H8ClF3N4
    Molecular Weight:228.6
    CAS Registry Number:762240-92-6
  • NETOBIMIN

    NETOBIMIN

    Product Name:NETOBIMIN
    Molecular Formula:C14H20N4O7S2
    Molecular Weight;420.46
    CAS Registry Number;88255-01-0
  • 2-Aminophenol

    2-Aminophenol

    Product Name:2-Aminophenol
    Molecular Formula:C6H7NO
    Molecular Weight:109.13
    CAS Registry Number:95-55-6
  • Ligustrazine Hydrochloride

    Ligustrazine Hydrochloride

    Product Name:Ligustrazine Hydrochloride
    Molecular Formula:C8H12N2.ClH
    Molecular Weight;172.658
    CAS Registry Number;76494-51-4
  • Fluconazole

    Fluconazole

    Product Name:Fluconazole
    Molecular Formula:C13H12F2N6O
    Molecular Weight:306.27
    CAS Registry Number:86386-73-4
  • Nystatin

    Nystatin

    Product Name:Nystatin
    Molecular Formula:C47H75NO17
    Molecular Weight;926.09
    CAS Registry Number;1400-61-9
  • Related Blog
  • Reviews

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept